Communiqués de presse Amgen — News Releases Santé & sciences de la vie — Flux RSS et veille en direct
PPN World indexe les communiqués de presse de Amgen — News Releases et en archive chaque publication. Ce fil est silencieux depuis le 7 juin 2026 — ses 10 communiqués indexés restent consultables, et une alerte vous préviendra dès qu'il publiera de nouveau.
URL du flux RSS de Amgen — News Releases
https://investors.amgen.com/rss/news-releases.xmlÀ propos de ce fil
Amgen — News Releases fait partie des 1000+ fils de presse que PPN World surveille en continu — un fil en anglais axé sur le secteur Santé & sciences de la vie, classé sous « États-Unis » dans notre index par pays. Chaque communiqué est dédupliqué, géolocalisé et enrichi d'un résumé IA, et vous pouvez y attacher des alertes sur recherches enregistrées. Le communiqué le plus récent de notre index a été publié le 7 juin 2026; le fil est silencieux depuis.
Comment suivre les communiqués de Amgen — News Releases
- Copiez l'URL du flux RSS de Amgen — News Releases affichée ci-dessus.
- Collez-la dans n'importe quel lecteur RSS (Feedly, Inoreader, NetNewsWire…) pour recevoir le flux brut.
- Ou suivez Amgen — News Releases dans PPN World pour ajouter déduplication, alertes sur recherches enregistrées et résumés IA sur les 1000+ fils.
Communiqués de Amgen — News Releases — archives
- AMGEN PRESENTS NEW DATA ACROSS ITS CARDIOMETABOLIC PORTFOLIO AT AMERICAN DIABETES ASSOCIATION 86TH SCIENTIFIC SESSIONSil y a 47 j
VESALIUS-CV Subgroup Results Show Repatha ® Reduces Risk of First Major Cardiovascular Events by 29% in People Living with High-Risk Diabetes New Real-World Data Highlight Treatment Gaps in Current Ob…
- AMGEN TO PRESENT AT THE GOLDMAN SACHS 47TH ANNUAL GLOBAL HEALTHCARE CONFERENCEil y a 50 j
THOUSAND OAKS, Calif., June 4, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Goldman Sachs 47 th Annual Global Healthcare Conference at 9:20 a.m. ET on Tuesday, June 9, 2026. Peter Grif…
- AMGEN TO PRESENT NEW DATA ACROSS RARE AUTOIMMUNE AND INFLAMMATORY DISEASES AT EULAR 2026il y a 52 j
New Phase 3 MITIGATE Open-Label Extension Data Support the Long-Term Safety Profile and Sustained Results of UPLIZNA ® in IgG4-RD Real-World Evidence Supports TAVNEOS ® Efficacy and Safety Profile wit…
- EUROPEAN COMMISSION APPROVES AMGEN'S IMDYLLTRA® FOR THE TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUNG CANCERil y a 53 j
Approval Based Upon Phase 3 DeLLphi-304 Trial Demonstrating 40% Reduction in Risk of Death with IMDYLLTRA Compared to Chemotherapy Novel Treatment Option for Patients with Extensive-Stage Small Cell L…
- AMGEN TO PRESENT AT JEFFERIES GLOBAL HEALTHCARE CONFERENCEil y a 56 j
THOUSAND OAKS, Calif., May 29, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at Jefferies Global Healthcare Conference at 9:55 a.m. ET on Thursday, June 4, 2026. Peter Griffith, executive vice…
- AMGEN ANNOUNCES RETIREMENT OF CHIEF FINANCIAL OFFICER PETER GRIFFITHil y a 66 j
Thomas Dittrich Returning to Amgen as CFO THOUSAND OAKS, Calif., May 19, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the retirement of Peter Griffith, who has served as the company's exec…
- AMGEN TO PRESENT AT THE BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCEil y a 78 j
THOUSAND OAKS, Calif., May 7, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Bank of America Merrill Lynch Global Healthcare Conference at 10:00 a.m. PT on Wednesday, May 13, 2026. Peter…
- AMGEN ANNOUNCES ADDITIONAL $300 MILLION U.S. MANUFACTURING INVESTMENT, TOTALING NEARLY $2 BILLION OVER THE LAST YEARil y a 82 j
Investment Strengthens American Manufacturing, Supply Chain Resilience and Next-Generation Technology THOUSAND OAKS, Calif., May 4, 2026 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced plans to i…
- AMGEN REPORTS FIRST QUARTER 2026 FINANCIAL RESULTSil y a 85 j
THOUSAND OAKS, Calif., April 30, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced financial results for the first quarter of 2026. "Our first quarter results demonstrate the strength of our bu…
- AMGEN ANNOUNCES WEBCAST OF 2026 FIRST QUARTER FINANCIAL RESULTSil y a 91 j
THOUSAND OAKS, Calif., April 24, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its first quarter 2026 financial results on Thursday, April 30, 2026, after the close of t…
Les plus récents communiqués de ce fil défilent en direct pour les membres PPN World.